Aktive Positionen von Michelle Rashford
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RACE ONCOLOGY LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2023 | - |
Karriereverlauf von Michelle Rashford
Ehemalige bekannte Positionen von Michelle Rashford
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Kyowa Kirin, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2020 | 01.10.2022 |
Hangzhou Adlai Nortye Biopharma Co. Ltd.
 Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2018 | 01.06.2020 |
Statistik
International
| Australien | 2 |
| China | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RACE ONCOLOGY LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Health Technology |
| Kyowa Kirin, Inc. |
- Börse
- Insiders
- Michelle Rashford
- Erfahrung
